The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Cachexia Market Research Report 2024
Synopsis
Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors.
The global Cancer Cachexia market was valued at US$ 1613.5 million in 2023 and is anticipated to reach US$ 2220.1 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
North American market for Cancer Cachexia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Cachexia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cancer Cachexia in Hospital Stores is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cancer Cachexia include Aeterna Zentaris, Alder BioPharmaceuticals, Aphios, Eli Lilly, GTx, Helsinn, Merck, Novartis and Bristol-Myers Squibb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Cachexia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Cachexia.
Report Scope
The Cancer Cachexia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Cachexia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Cachexia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aeterna Zentaris
Alder BioPharmaceuticals
Aphios
Eli Lilly
GTx
Helsinn
Merck
Novartis
Bristol-Myers Squibb
XBiotech
Segment by Type
Progestogens
Corticosteroids
Combination Therapies
Others
Segment by Application
Hospital Stores
Retails Pharmacy Store
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Cachexia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors.
The global Cancer Cachexia market was valued at US$ 1613.5 million in 2023 and is anticipated to reach US$ 2220.1 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
North American market for Cancer Cachexia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Cachexia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cancer Cachexia in Hospital Stores is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cancer Cachexia include Aeterna Zentaris, Alder BioPharmaceuticals, Aphios, Eli Lilly, GTx, Helsinn, Merck, Novartis and Bristol-Myers Squibb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Cachexia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Cachexia.
Report Scope
The Cancer Cachexia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Cachexia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Cachexia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aeterna Zentaris
Alder BioPharmaceuticals
Aphios
Eli Lilly
GTx
Helsinn
Merck
Novartis
Bristol-Myers Squibb
XBiotech
Segment by Type
Progestogens
Corticosteroids
Combination Therapies
Others
Segment by Application
Hospital Stores
Retails Pharmacy Store
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Cachexia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Cachexia Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Progestogens
1.2.3 Corticosteroids
1.2.4 Combination Therapies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cancer Cachexia Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Stores
1.3.3 Retails Pharmacy Store
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Cachexia Market Perspective (2019-2030)
2.2 Cancer Cachexia Growth Trends by Region
2.2.1 Global Cancer Cachexia Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Cachexia Historic Market Size by Region (2019-2024)
2.2.3 Cancer Cachexia Forecasted Market Size by Region (2025-2030)
2.3 Cancer Cachexia Market Dynamics
2.3.1 Cancer Cachexia Industry Trends
2.3.2 Cancer Cachexia Market Drivers
2.3.3 Cancer Cachexia Market Challenges
2.3.4 Cancer Cachexia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Cachexia Players by Revenue
3.1.1 Global Top Cancer Cachexia Players by Revenue (2019-2024)
3.1.2 Global Cancer Cachexia Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Cachexia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Cachexia Revenue
3.4 Global Cancer Cachexia Market Concentration Ratio
3.4.1 Global Cancer Cachexia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Cachexia Revenue in 2023
3.5 Cancer Cachexia Key Players Head office and Area Served
3.6 Key Players Cancer Cachexia Product Solution and Service
3.7 Date of Enter into Cancer Cachexia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Cachexia Breakdown Data by Type
4.1 Global Cancer Cachexia Historic Market Size by Type (2019-2024)
4.2 Global Cancer Cachexia Forecasted Market Size by Type (2025-2030)
5 Cancer Cachexia Breakdown Data by Application
5.1 Global Cancer Cachexia Historic Market Size by Application (2019-2024)
5.2 Global Cancer Cachexia Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Cachexia Market Size (2019-2030)
6.2 North America Cancer Cachexia Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Cachexia Market Size by Country (2019-2024)
6.4 North America Cancer Cachexia Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Cachexia Market Size (2019-2030)
7.2 Europe Cancer Cachexia Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Cachexia Market Size by Country (2019-2024)
7.4 Europe Cancer Cachexia Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Cachexia Market Size (2019-2030)
8.2 Asia-Pacific Cancer Cachexia Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Cachexia Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Cachexia Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Cachexia Market Size (2019-2030)
9.2 Latin America Cancer Cachexia Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Cachexia Market Size by Country (2019-2024)
9.4 Latin America Cancer Cachexia Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Cachexia Market Size (2019-2030)
10.2 Middle East & Africa Cancer Cachexia Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Cachexia Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Cachexia Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aeterna Zentaris
11.1.1 Aeterna Zentaris Company Detail
11.1.2 Aeterna Zentaris Business Overview
11.1.3 Aeterna Zentaris Cancer Cachexia Introduction
11.1.4 Aeterna Zentaris Revenue in Cancer Cachexia Business (2019-2024)
11.1.5 Aeterna Zentaris Recent Development
11.2 Alder BioPharmaceuticals
11.2.1 Alder BioPharmaceuticals Company Detail
11.2.2 Alder BioPharmaceuticals Business Overview
11.2.3 Alder BioPharmaceuticals Cancer Cachexia Introduction
11.2.4 Alder BioPharmaceuticals Revenue in Cancer Cachexia Business (2019-2024)
11.2.5 Alder BioPharmaceuticals Recent Development
11.3 Aphios
11.3.1 Aphios Company Detail
11.3.2 Aphios Business Overview
11.3.3 Aphios Cancer Cachexia Introduction
11.3.4 Aphios Revenue in Cancer Cachexia Business (2019-2024)
11.3.5 Aphios Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Cancer Cachexia Introduction
11.4.4 Eli Lilly Revenue in Cancer Cachexia Business (2019-2024)
11.4.5 Eli Lilly Recent Development
11.5 GTx
11.5.1 GTx Company Detail
11.5.2 GTx Business Overview
11.5.3 GTx Cancer Cachexia Introduction
11.5.4 GTx Revenue in Cancer Cachexia Business (2019-2024)
11.5.5 GTx Recent Development
11.6 Helsinn
11.6.1 Helsinn Company Detail
11.6.2 Helsinn Business Overview
11.6.3 Helsinn Cancer Cachexia Introduction
11.6.4 Helsinn Revenue in Cancer Cachexia Business (2019-2024)
11.6.5 Helsinn Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Cancer Cachexia Introduction
11.7.4 Merck Revenue in Cancer Cachexia Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Cancer Cachexia Introduction
11.8.4 Novartis Revenue in Cancer Cachexia Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Cancer Cachexia Introduction
11.9.4 Bristol-Myers Squibb Revenue in Cancer Cachexia Business (2019-2024)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 XBiotech
11.10.1 XBiotech Company Detail
11.10.2 XBiotech Business Overview
11.10.3 XBiotech Cancer Cachexia Introduction
11.10.4 XBiotech Revenue in Cancer Cachexia Business (2019-2024)
11.10.5 XBiotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
